lilly zepbound - Search News

News

Eli Lilly, weight loss and GLP-1

Axios on MSN · 1h

GLP-1 pill: Eli Lilly says its oral orforglipron showing "promising results"

A new oral GLP-1 drug candidate could transform the diabetes and weight loss drug boom. Why it matters: Eli Lilly said on Thursday that its experimental pill — called orforglipron — is showing promising results and could serve as an alternative to blockbuster injectable medications like Ozempic and Mounjaro.

CBS News on MSN · 5h

GLP-1 pill shows success for diabetes, weight loss, Eli Lilly says

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced success Thursday of its Phase 3 clinical trial for a once-daily GLP-1 pill — an oral form of the blockbuster medication used for diabetes and weight loss.

Insider on MSN · 10h

Weight loss in a pill? Eli Lilly just took a big step closer to making it happen.

Eli Lilly GLP-1 pill orforglipron could revolutionize the weight loss world by the end of 2025 after promising Phase 3 trial results.

6d

Lilly’s Zepbound Keeps Weight Off for Three Years, Study Finds

Patients regularly taking Eli Lilly & Co.’s obesity shot Zepbound tend to keep the weight off for at least three years, with ...

7h

Eli Lilly: Cementing Its GLP-1 Empire With Orforglipron's Promising Phase 3 Results

Eli Lilly's oral GLP-1 drug orforglipron showed strong Phase 3 results with 7.9% weight loss and good tolerability, ...

16don MSN

Eli Lilly sues two pharmacies making copycat Zepbound, Mounjaro

Eli Lilly is suing Strive Pharmacy and Empower Pharmacy for compounding tirzepatide, the active ingredient in Zepbound and Mounjaro.

15don MSN

Hims & Hers Expands Weight Loss Offering, Adds Lilly’s Zepbound to Platform

The telehealth-consultation platform said it plans to continue expanding its weight loss offerings.

3don MSN

Wegovy, Zepbound makers’ stocks rally as a weight-loss-drug competitor drops out

Pfizer’s announcement that it will stop developing its oral weight-loss drug gave shares of Wegovy maker Novo Nordisk and ...

8dOpinion

Trump-Powered Medicare Setback Adds Bullish Impetus for Eli Lilly & Co (LLY) Stock

After massive gains in the past five years on the heels of the weight loss blockbuster Zepbound, Eli Lilly & Co (LLY) stock ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results